Talk:Choline bitartrate: Difference between revisions
>David Hedlund m removed unknown characteristics |
>David Hedlund ping|Clarity |
||
| Line 7: | Line 7: | ||
{{ping|Clarity}} | {{ping|Clarity}} | ||
{{ping|Clarity}} Can you please confirm my findings and add some text about this to the page? --[[User:David Hedlund|David Hedlund]] ([[User talk:David Hedlund|talk]]) 23:43, 24 March 2018 (UTC) | |||
Revision as of 23:43, 24 March 2018
DL-choline bitartrate
Choline is often sold as a supplement without any CAS provided
“DL-Choline Bitartrate should not be used in pharma or food applications although the price is normally more attractive. Studies have that shown the DL-form has nefrotoxic effects (1). In Europe, according to the CODEX and European Union, only L-Choline Bitartrate is allowed because it is mentioned in DAB and in the USP monograph. The DL form does not comply with these monographs. Moreover, according to the FDA, L-Choline Bitartrate is considered GRAS affirmed (21CFR182.8250_2010) but not the DL-form.” – http://www.geelawsonnutritional.com/news/gee-lawson-news/42-what-you-are-buying-might-not-be-the-right-source-of-choline.html
“Urolithiasis in rats consuming a dl bitartrate form of choline in a purified diet.” – https://www.ncbi.nlm.nih.gov/pubmed/16158911 — Urolithiasis = Kidney stone disease
@Clarity:
@Clarity: Can you please confirm my findings and add some text about this to the page? --David Hedlund (talk) 23:43, 24 March 2018 (UTC)